(Q34774456)

4 August 2017

1 reference

title

Origin of symptoms in patients with cachexia with special reference to weakness and shortness of breath (English)

1 reference

4 August 2017

1 reference

Andrew J S Coats

1

1 reference

4 August 2017

publication date

1 September 2002

1 reference

International Journal of Cardiology

4 August 2017

published in

1 reference

4 August 2017

volume

85

1 reference

4 August 2017

issue

1

1 reference

4 August 2017

page(s)

133-139

1 reference

Dyspnea and 8-year mortality among elderly men and women: the PAQUID cohort study

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

Pulmonary versus systemic hemodynamics in determining exercise capacity of patients with chronic left ventricular failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

The clinical impact of dynamic intraventricular obstruction during dobutamine stress echocardiography

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

Exercise limitation in chronic heart failure: central role of the periphery

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

Active skeletal muscle mass and cardiopulmonary reserve. Failure to attain peak aerobic capacity during maximal bicycle exercise in patients with severe congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

Central and peripheral components of chronic heart failure: determinants of exercise tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

Alterations of skeletal muscle in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

Abnormalities in the regional circulations accompanying congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

Endogenous nitric oxide in patients with chronic heart failure (CHF): relation to functional impairment and nitrate-containing therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

The lungs in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

Predictors of exercise capacity in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

Skeletal muscle metabolism during exercise under ischemic conditions in congestive heart failure. Evidence for abnormalities unrelated to blood flow

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

Tumor necrosis factor and steroid metabolism in chronic heart failure: possible relation to muscle wasting

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

Insulin resistance in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

Wasting as independent risk factor for mortality in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

Uric acid in cachectic and noncachectic patients with chronic heart failure: relationship to leg vascular resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

Relation between chemosensitivity and the ventilatory response to exercise in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

Contribution of muscle afferents to the hemodynamic, autonomic, and ventilatory responses to exercise in patients with chronic heart failure: effects of physical training

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

The Ergoreflex in patients with chronic stable heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

Enhanced ventilatory response to exercise in patients with chronic heart failure and preserved exercise tolerance: marker of abnormal cardiorespiratory reflex control and predictor of poor prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

Cardiopulmonary exercise parameters in relation to all-cause mortality in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

Role of the etiology of cardiomyopathies on exercise capacity and oxygen consumption in patients with severe congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

Shuttle versus six-minute walk test in the prediction of outcome in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

Cardiopulmonary exercise testing for prognosis in chronic heart failure: continuous and independent prognostic value from VE/VCO(2)slope and peak VO(2).

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

The impact of cachexia on cardiorespiratory reflex control in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

Evidence of reduced respiratory muscle endurance in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

The pathological consequences of anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

A neural link to explain the "muscle hypothesis" of exercise intolerance in chronic heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

Contribution of peripheral chemoreceptors to ventilation and the effects of their suppression on exercise tolerance in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

Inflammation, hormones, the blood and the heart; are cardiologists learning to be internists again?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

The role of inflammatory mediators in chronic heart failure: cytokines, nitric oxide, and endothelin-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

High tumour necrosis factor-alpha levels are associated with exercise intolerance and neurohormonal activation in chronic heart failure patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

Insulin resistance in moderate chronic heart failure is related to hyperleptinaemia, but not to norepinephrine or TNF-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

Treatment of protein-energy malnutrition in chronic nonmalignant disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

The effect of salbutamol on skeletal muscle in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

Inflammatory mediators in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

Management of dyspnea in advanced cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

Dyspnea: pathophysiology and assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

Experimental pain augments experimental dyspnea, but not vice versa in human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

The relationship of nausea and dyspnea to pain in seriously ill patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

Exercise-limiting factors in respiratory distress

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

Respiratory muscle dysfunction associated with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

Cardiac autonomic dysfunction in AIDS is not secondary to heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

Development of a patient-specific dyspnoea questionnaire in motor neurone disease (MND): the MND dyspnoea rating scale (MDRS)

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

Dyspnea in dystonia. A functional evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

Respiratory Dyskinesias: Extrapyramidal Dysfunction and Dyspnea

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

Consider 'hyperviscosity syndrome' in unexplained breathlessness

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

Effect of intravenous fructose 1,6-diphosphate administration in malnourished chronic obstructive pulmonary disease patients with chronic respiratory failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

Effect of octreotide on ventilation and dyspnea sensation in a patient with cirrhotic hypoxemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

Thwarting the dwindling progression of cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900242-5

7 January 2021

10.1016/S0167-5273(02)00242-5

Identifiers

DOI

1 reference

4 August 2017

1 reference